Correlation Between BioNTech and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Novavax, you can compare the effects of market volatilities on BioNTech and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Novavax.

Diversification Opportunities for BioNTech and Novavax

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between BioNTech and Novavax is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of BioNTech i.e., BioNTech and Novavax go up and down completely randomly.

Pair Corralation between BioNTech and Novavax

Given the investment horizon of 90 days BioNTech SE is expected to generate 0.55 times more return on investment than Novavax. However, BioNTech SE is 1.8 times less risky than Novavax. It trades about 0.02 of its potential returns per unit of risk. Novavax is currently generating about -0.05 per unit of risk. If you would invest  11,993  in BioNTech SE on October 31, 2024 and sell it today you would earn a total of  123.00  from holding BioNTech SE or generate 1.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  Novavax

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Novavax 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Novavax is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

BioNTech and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Novavax

The main advantage of trading using opposite BioNTech and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind BioNTech SE and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA